C3 and hepatocellular carcinoma: Other studies, like Wang et al.57showed that CLU had prognostic value in HCC. Chen et al.58showed that C3 also had prognostic value in HCC. Thus, we considered these complement genes might also serve as prognostic biomarkers in clinic after further validation.